DNAJC21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.326000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.691200E-01
Normal-vs-Stage2
2.308000E-01
Normal-vs-Stage3
3.678600E-01
Normal-vs-Stage4
1.270630E-01
Stage1-vs-Stage2
8.667400E-01
Stage1-vs-Stage3
3.179800E-01
Stage1-vs-Stage4
1.259970E-01
Stage2-vs-Stage3
2.701600E-01
Stage2-vs-Stage4
1.189390E-01
Stage3-vs-Stage4
5.326100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.217800E-01
Normal-vs-AfricanAmerican
2.451000E-01
Normal-vs-Asian
6.694000E-01
Caucasian-vs-AfricanAmerican
1.677550E-01
Caucasian-vs-Asian
7.260200E-01
AfricanAmerican-vs-Asian
4.990800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.164000E-01
Normal-vs-Female
2.992400E-01
Male-vs-Female
6.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.206200E-01
Normal-vs-Age(41-60Yrs)
1.625640E-02
Normal-vs-Age(61-80Yrs)
9.436600E-01
Normal-vs-Age(81-100Yrs)
9.093800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.850600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.148800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.389000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.659900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.732750E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.190800E-01
Normal-vs-Daily Drinker
3.891800E-01
Normal-vs-Weekly Drinker
2.729000E-01
Normal-vs-Occasional Drinker
1.322990E-01
Normal-vs-Social Drinker
4.639600E-01
Non Drinker-vs-Daily Drinker
7.236000E-01
Non Drinker-vs-Weekly Drinker
1.245420E-01
Non Drinker-vs-Occasional Drinker
7.757800E-02
Non Drinker-vs-Social Drinker
2.881800E-01
Daily Drinker-vs-Weekly Drinker
1.309020E-01
Daily Drinker-vs-Occasional Drinker
8.090000E-02
Daily Drinker-vs-Social Drinker
2.498400E-01
Weekly Drinker-vs-Occasional Drinker
9.224600E-01
Weekly Drinker-vs-Social Drinker
5.967000E-01
Occasional Drinker-vs-Social Drinker
5.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.198600E-01
Normal-vs-Grade 2
9.995800E-01
Normal-vs-Grade 3
9.744400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.398170E-01
Grade 1-vs-Grade 3
5.752300E-02
Grade 1-vs-Grade 4
9.198600E-01
Grade 2-vs-Grade 3
4.821000E-01
Grade 2-vs-Grade 4
9.995800E-01
Grade 3-vs-Grade 4
9.744400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.390200E-01
Normal-vs-NonDiabetic
7.657600E-01
Diabetic-vs-NonDiabetic
9.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.975440E-01
Normal-vs-NoPancreatitis
7.363200E-01
Pancreatitis-vs-NoPancreatitis
3.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.878600E-01
Normal-vs-N1
3.026400E-01
N0-vs-N1
8.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.920800E-01
Normal-vs-TP53-NonMutant
8.158600E-01
TP53-Mutant-vs-TP53-NonMutant
5.082500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
